The IL-6/STAT3 pathway is a major component of chronic liver diseases and HCC development by controlling the innate immune response [163] but also the expression of mitogenic/survival factors in hepatocytes (e.g., MYC), thereby promoting hepatic carcinogenesis [164]. Here, STAT3 is linked to hepatocellular carcinoma.